BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8000245)

  • 1. Experimental study on the hyperplasia of juxtaglomerular cells under low-dose, long-term administration of calcium chelating agents. Similar to the morphological manifestation of Bartter's syndrome.
    Yamaguchi H; Kaku H; Onodera TA; Kurokawa R; Morisada M
    Exp Toxicol Pathol; 1994 Aug; 46(3):237-41. PubMed ID: 8000245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Morphology of the juxtaglomerular appartus in Bartter's syndrome (hyperplasia of the juxtaglomerular complex with secondary aldosteronism without hypertension)].
    Herranz P; Ceballos L; Herranz G
    Rev Med Univ Navarra; 1974; 18(1-2):35-46. PubMed ID: 4470831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristic changes of the juxtaglomerular cells before and after treatment of pseudo-Bartter's syndrome due to furosemide abuse.
    Mizuiri S; Ozawa T; Hirata K; Takezawa K; Kawamura S
    Nephron; 1987; 46(1):23-7. PubMed ID: 3600908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripolar cells in guinea pigs under experimental hyperplasia of juxtaglomerular cells induced by long-term, low-dose calcium condition.
    Yamaguchi H; Kaku H; Onodera T; Kurokawa R; Morisada M
    Exp Toxicol Pathol; 1994 Oct; 46(4-5):283-6. PubMed ID: 7894237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional interpretation of the kidney juxtaglomerular apparatus using renin immunohistochemistry in Bartter's, pseudo-Bartter's and Conn's syndromes.
    Lertprasertsuke N; Kakudo K; Osamura Y; Nomoto Y; Sakai H; Watanabe K
    Tokai J Exp Clin Med; 1990 Jul; 15(4):317-26. PubMed ID: 2130539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bartter's syndrome--case report.
    Miyoshi A; Makino H; Hiramatsu M; Takahashi K; Yamane Y; Takahara J; Suzuki S; Ota Z; Ofuji T; Takehisa Y
    Acta Med Okayama; 1979 Aug; 33(4):305-14. PubMed ID: 158951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bartter's syndrome with hyperplasia of renomedullary cells: successful treatment with indomethacin.
    Verberckmoes R; van Damme B B; Clement J; Amery A; Michielsen P
    Kidney Int; 1976 Mar; 9(3):302-7. PubMed ID: 940272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bartter's syndrome without hyperplasia of the juxtaglomerular apparatus, treated with indomethacin.
    Kornerup HJ; Pedersen EB; Petersen VP
    Acta Med Scand; 1978; 204(3):235-9. PubMed ID: 696424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative estimation of renin-containing cells in the juxtaglomerular apparatus in Bartter's and pseudo-Bartter's syndromes.
    Okada M; Lertprasertsuke N; Tsutsumi Y
    Pathol Int; 2000 Feb; 50(2):166-8. PubMed ID: 10792778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The juxtaglomerular apparatus in Bartter's syndrome and related tubulopathies. An immunocytochemical and electron microscopic study.
    Taugner R; Waldherr R; Seyberth HW; Erdös EG; Menard J; Schneider D
    Virchows Arch A Pathol Anat Histopathol; 1988; 412(5):459-70. PubMed ID: 3128915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Proceedings: Comparative morphologic studies of the juxtaglomerular apparatus in Addison's disease and in Bartter's syndrome].
    Christensen J
    Verh Dtsch Ges Pathol; 1974; 58():486. PubMed ID: 4460514
    [No Abstract]   [Full Text] [Related]  

  • 12. Histological and ultrastructural studies of the human juxtaglomerular apparatus in Bartter's syndrome and renal artery stenosis.
    McLaren KM; MacDonald MK
    J Pathol; 1982 Mar; 136(3):181-97. PubMed ID: 6175738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bartter's syndrome.
    Bartter FC; Gill JR; Frolich JC
    Adv Nephrol Necker Hosp; 1977; 7():191-8. PubMed ID: 96673
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypokalemic alkalosis, hyperreninemia, aldosteronism, normal blood pressure and normal juxtaglomerular apparatus--a new syndrome of renal alkalosis.
    Barakat AY; Francis YK; Mufarrij AA
    Int J Pediatr Nephrol; 1986; 7(2):99-100. PubMed ID: 3522459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical analysis of drug-induced Pseudo-Bartter's syndrome: a report of five cases].
    Li FA; Wei HY; Lin S; Han HL; Qiu MC
    Zhonghua Yi Xue Za Zhi; 2012 May; 92(18):1278-80. PubMed ID: 22883069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hypertrophy of the juxtaglomerular apparatus with hyperaldosteronism and potassium depletion, without hypertension, or edema (Bartter's syndrome)].
    Díes F; Herrera J; Peña JC; López Amor E
    Rev Invest Clin; 1969; 21(3):331-46. PubMed ID: 5317587
    [No Abstract]   [Full Text] [Related]  

  • 17. [Histopathology of the kidney in pseudo-Bartter's Syndrome induced by chronic abuse of diuretics (author's transl)].
    Wagner PK; Pippig L; Thoenes W
    Klin Wochenschr; 1979 Feb; 57(3):135-42. PubMed ID: 439780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unilateral juxtaglomerular hyperplasia, hyperreninism and hypokalaemia relieved by nephrectomy.
    Kuchel O; Horky K; Cantin M; Roy P
    J Hum Hypertens; 1993 Feb; 7(1):71-8. PubMed ID: 8450525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nephropathologic characteristics of a woman with Bartter's syndrome after prolonged treatment with spironolactone.
    Nakada T; Shigematsu H; Bartter FC; Delea CS
    Nephron; 1980; 26(2):78-84. PubMed ID: 7412963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bartter's syndrome in pregnancy: a case report and review.
    O'Sullivan E; Monga M; Graves W
    Am J Perinatol; 1997 Jan; 14(1):55-7. PubMed ID: 9259898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.